Icosagen Group: Funding, Investors & Team (Sep 2026)
High-end biotechnology services and goods are provided by the Icosagen Group, a contract research organisation and technology developer for the biopharmaceutical and biotechnology sectors of industry and academia. The business offers services such as protein, antibody, and VLP manufacturing. Products include ELISA kits, transfection reagent, proteins, antibodies, and DNA/RNA isolation Additionally, it provides quality assurance services like FITkit for checking latex allergens and food microbiological testing services. The Icosagen Group takes part in numerous national and international research initiatives, such as INTENSO, MAARS, and EURIPRED.
Icosagen Group has raised $19.4M across 1 funding round on record, the most recent an undisclosed round of $19.4M announced in Feb 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Icosagen Group Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Icosagen Group Funding Rounds
Icosagen Group Founders and Leadership Team
Contact details for the Icosagen Group team: 1 of 1 has an email address on file.
Start 14-day free trial →Icosagen Group Funding Compared to Other Biotechnology Startups
Icosagen Group's latest round of $19.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Icosagen Group in Biotechnology and Tartu
Companies Similar to Icosagen Group
Gearbox Biosciences, a biotech firm located in Tartu, Estonia, specializes in offering innovative technology…
Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations…
Decomer Technology is develops a novel water-soluble and edible packaging material and products thereof.
Gelatex is a Techstars-backed materials technology company that invented the fastest technology for producing…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Icosagen Group Funding FAQs
What does Icosagen Group do?
High-end biotechnology services and goods are provided by the Icosagen Group, a contract research organisation and technology developer for the biopharmaceutical and biotechnology sectors of industry and academia. The business offers services such as protein, antibody, and VLP manufacturing. Products include ELISA kits, transfection reagent, proteins, antibodies, and DNA/RNA isolation Additionally, it provides quality assurance services like FITkit for checking latex allergens and food microbiological testing services. The Icosagen Group takes part in numerous national and international research initiatives, such as INTENSO, MAARS, and EURIPRED.
How much funding has Icosagen Group raised?
Icosagen Group has raised $19.4M across 1 round on record. The most recent is an undisclosed round of $19.4M announced in Feb 2023.
When did Icosagen Group last raise funding?
Icosagen Group's most recent funding round on record is an undisclosed round of $19.4M, announced in Feb 2023.
Who is the CEO of Icosagen Group?
Mart Ustav is listed as CEO at Icosagen Group.
Where is Icosagen Group headquartered?
Icosagen Group is based in Tartu, Tartumaa, Estonia.
How many employees does Icosagen Group have?
Icosagen Group is in the 1-10 employee band.
How does Icosagen Group's funding compare to other Biotechnology startups?
Icosagen Group's latest round of $19.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Icosagen Group Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Icosagen Group is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.